A new trading day began on Monday, with Altimmune Inc (NASDAQ: ALT) stock price down -0.20% from the previous day of trading, before settling in for the closing price of $5.07. ALT’s price has ranged from $3.55 to $11.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 104.92% over the past five years. Meanwhile, its annual earnings per share averaged -6.99%. With a float of $76.21 million, this company’s outstanding shares have now reached $77.01 million.
Let’s look at the performance matrix of the company that is accounted for 59 employees. In terms of profitability, gross margin is -740.0%, operating margin of -515860.0%, and the pretax margin is -475295.0%.
Altimmune Inc (ALT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Altimmune Inc is 1.04%, while institutional ownership is 53.20%. The most recent insider transaction that took place on Mar 17 ’25, was worth 5,784. In this transaction Director of this company bought 1,000 shares at a rate of $5.78, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Mar 13 ’25, when Company’s Chief Financial Officer bought 10,000 for $5.20, making the entire transaction worth $51,996. This insider now owns 10,000 shares in total.
Altimmune Inc (ALT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.77% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Here are Altimmune Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19484.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Altimmune Inc (NASDAQ: ALT) saw its 5-day average volume 1.56 million, a negative change from its year-to-date volume of 2.43 million. As of the previous 9 days, the stock’s Stochastic %D was 86.40%. Additionally, its Average True Range was 0.35.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 20.57%, which indicates a significant decrease from 89.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.28% in the past 14 days, which was higher than the 72.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.38, while its 200-day Moving Average is $6.70. Nevertheless, the first resistance level for the watch stands at $5.22 in the near term. At $5.37, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.52. If the price goes on to break the first support level at $4.92, it is likely to go to the next support level at $4.77. Assuming the price breaks the second support level, the third support level stands at $4.62.
Altimmune Inc (NASDAQ: ALT) Key Stats
With a market capitalization of 389.69 million, the company has a total of 77,014K Shares Outstanding. Currently, annual sales are 20 K while annual income is -95,060 K. The company’s previous quarter sales were 10 K while its latest quarter income was -23,180 K.
